These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging. Xie P, Du P, Li J, Liu P. Carbohydr Polym; 2019 Feb 01; 205():377-384. PubMed ID: 30446118 [Abstract] [Full Text] [Related]
5. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting. Gautier J, Munnier E, Paillard A, Hervé K, Douziech-Eyrolles L, Soucé M, Dubois P, Chourpa I. Int J Pharm; 2012 Feb 14; 423(1):16-25. PubMed ID: 21703340 [Abstract] [Full Text] [Related]
6. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. Wang C, Zhang Z, Chen B, Gu L, Li Y, Yu S. J Colloid Interface Sci; 2018 Apr 15; 516():332-341. PubMed ID: 29408121 [Abstract] [Full Text] [Related]
7. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery. Elbialy NS, Fathy MM, Khalil WM. Int J Pharm; 2015 Jul 25; 490(1-2):190-9. PubMed ID: 25997662 [Abstract] [Full Text] [Related]
8. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug. Sahoo B, Devi KS, Banerjee R, Maiti TK, Pramanik P, Dhara D. ACS Appl Mater Interfaces; 2013 May 25; 5(9):3884-93. PubMed ID: 23551195 [Abstract] [Full Text] [Related]
9. Magnetic targeted drug delivery carriers encapsulated with pH-sensitive polymer: synthesis, characterization and in vitro doxorubicin release studies. Wu J, Shen Y, Jiang W, Jiang W, Shen Y. J Biomater Sci Polym Ed; 2016 Sep 25; 27(13):1303-16. PubMed ID: 27252073 [Abstract] [Full Text] [Related]
12. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. He Y, Su Z, Xue L, Xu H, Zhang C. J Control Release; 2016 May 10; 229():80-92. PubMed ID: 26945977 [Abstract] [Full Text] [Related]
13. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers. Elbialy NS, Fathy MM, Khalil WM. Phys Med; 2014 Nov 10; 30(7):843-8. PubMed ID: 24950615 [Abstract] [Full Text] [Related]
17. PEGylated magnetic Prussian blue nanoparticles asa multifunctional therapeutic agent for combined targeted photothermal ablation and pH-triggered chemotherapy of tumour cells. Xue P, Sun L, Li Q, Zhang L, Xu Z, Li CM, Kang Y. J Colloid Interface Sci; 2018 Jan 01; 509():384-394. PubMed ID: 28923735 [Abstract] [Full Text] [Related]
19. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F, Zheng C, Xin J, Chen F, Ling H, Sun L, Webster TJ, Ming X, Liu J. Int J Nanomedicine; 2016 Jan 01; 11():3875-90. PubMed ID: 27574421 [Abstract] [Full Text] [Related]
20. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy. Rajkumar S, Prabaharan M. Colloids Surf B Biointerfaces; 2018 Oct 01; 170():529-537. PubMed ID: 29966906 [Abstract] [Full Text] [Related] Page: [Next] [New Search]